Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Neurotoxicity research

• Publication date

  2022-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12640-022-00556-wPMID 36053462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective Features of Calorie Restriction on Cuprizone-induced Demyelination via Modulating Microglial Phenotype.

  2021cited by this paper
• Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice

  2021cited by this paper
• Therapeutic potential of stem cells for treatment of neurodegenerative diseases

  2020cited by this paper
• The Role of Macrophages in Vascular Repair and Regeneration after Ischemic Injury

  2020cited by this paper
• Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone‐induced demyelination mouse model

  2019cited by this paper
• The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.

  2019influential reference
• Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases

  2019cited by this paper
• Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination

  2019cited by this paper
• Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone‐induced demyelination model

  2019cited by this paper
• Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model

  2019cited by this paper
• MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial activation.

  2018cited by this paper
• BDNF haploinsufficiency exerts a transient and regionally different influence upon oligodendroglial lineage cells during postnatal development

  2018cited by this paper
• Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis

  2018cited by this paper
• Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures

  2018cited by this paper
• Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates

  2017cited by this paper
• Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4

  2017cited by this paper
• TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype

  2016cited by this paper
• Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage

  2016cited by this paper
• Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.

  2016cited by this paper
• Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF‐β Secretion

  2016cited by this paper
• Melatonin Pretreatment Enhances the Homing of Bone Marrow-derived Mesenchymal Stem Cells Following Transplantation in a Rat Model of Liver Fibrosis

  2016cited by this paper
• Mesenchymal stem cells promote augmented response of endogenous neural stem cells in spinal cord injury of rats

  2016cited by this paper
• Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice.

  2015cited by this paper
• Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.

  2015cited by this paper
• Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

  2015cited by this paper
• Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors

  2015cited by this paper
• Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis

  2014influential reference
• Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination

  2014cited by this paper
• Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats

  2014cited by this paper
• Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives

  2014cited by this paper
• Delayed Intranasal Delivery of Hypoxic-Preconditioned Bone Marrow Mesenchymal Stem Cells Enhanced Cell Homing and Therapeutic Benefits after Ischemic Stroke in Mice

  2013cited by this paper
• TGFβ signaling plays a critical role in promoting alternative macrophage activation

  2012cited by this paper
• Comparison of polarization properties of human adult microglia and blood‐derived macrophages

  2012cited by this paper
• Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination

  2012cited by this paper
• Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum

  2012cited by this paper
• Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases.

  2011cited by this paper
• Multiple Sclerosis: Pathogenesis and Treatment

  2011cited by this paper
• Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage

  2010cited by this paper
• Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis.

  2008cited by this paper
• Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

  2007influential reference
• Unravelling the chemical nature of copper cuprizone.

  2007cited by this paper
• Astrocyte activation and reactive gliosis

  2005cited by this paper
• The demonstration of recurrent demyelination and remyelination of axons in the central nervous system

  2004influential reference
• Multiple sclerosis: it's not the disease you thought it was.

  2003cited by this paper
• Translating stem and progenitor cell biology to the clinic: barriers and opportunities.

  2000cited by this paper
• Remyelination in multiple sclerosis

  1978cited by this paper

• Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice

  2026cites this paper
• Impaired therapeutic efficacy of sleep-deprived bone marrow mesenchymal stem cells in the cerebellum of mouse cuprizone model of multiple sclerosis: stereological and motor behavioral evidence

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Impact of Sleep Deprivation on Bone Marrow Mesenchymal Stem Cell-Mediated Remyelination in the Corpus Callosum of Male Mice

  2025cites this paper
• Role of mesenchymal stem-cell-based therapy in multiple sclerosis: insights from recent preclinical and clinical studies

  2025cites this paper
• Lutein improves remyelination by reducing of neuroinflammation in C57BL/6 mouse models of multiple sclerosis

  2024cites this paper
• Microglia/macrophage polarization regulates spontaneous remyelination in intermittent cuprizone model of demyelination

  2024cites this paper
• Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis.

  2023cites this paper